The direct cost incurred by patients and caregivers in diagnosing and managing prostate cancer in Ghana

Table 3 Price and availability details of prostate cancer pharmaceuticals in sampled community pharmacies

SN	Prostate cancer medication	Originator brand (OB) or Generic (G)	Strength	Dosage form/unit	Pack size	Unit MLCP GHC ($) [Range, GHC]	Unit MIRP GHC ($)	MDPR	% Availability (n = 10)
1	Abiraterone acetate	OB	250 mg^a	Tablet	120	39.42 (6.79) [33.75 - 65.70]			60.00
1	Abiraterone acetate	G	250 mg^a	Tablet	120	25.00 (4.31) [20.83 - 29.16]			20.00
2	Bicalutamide	OB	50 mg	Tablet	28	9.98 (1.72) [8.60 - 10.36]	1.36 (0.23)	7.34	60.00
		OB	150 mg	Tablet	28	27.60 (4.76) [21.07 - 32.86]	5.98 (1.03)	4.62	90.00
		G	50 mg	Tablet	28	3.00 (0.52) [1.80 - 6.90]	1.36 (0.23)	2.21	70.00
		G	150 mg	Tablet	28	4.29 (0.74) [3.05 - 8.40]	5.98 (1.03)	0.72	70.00
3	Docetaxel	G	20 mg	Injection	1	280.00 (48.26) [90.00 - 300.00]	235.10 (40.52)	1.19	30.00
		G	80 mg	Injection	1	400.00 (68.94) [350.00 - 560.00]	278.46 (47.99)	1.44	30.00
		G	120 mg^a	Injection	1	750.00 (129.26) [420.00 - 1200.00]			40.00
4	Flutamide	G	250 mg	Tablet	84	10.00 (1.72) [3.50 - 18.25]	0.65 (0.11)	15.38	50.00
5	Goserelin	OB	3.6 mg^a	Injection	1	662.50 (114.18) [530.00 - 689.00]			70.00
5	Goserelin	OB	10.8 mg^a	Injection	1	1700.00 (293.00) [1509.70 - 1958.80]			70.00
6	Mitoxantrone	G	20 mg^a	Injection	1	205.00 (35.33) [250]			10.00

MDPR = (MLCP ÷ MIRP); Mean Drug Availability (All Pharmacies) = 51.54%; Mean Drug Availability (Private Hospital Vicinity) = 41.54%; Mean Drug Availability (Public Hospital Vicinity) = 61.54%
MLCP Median Local Consumer Price, MIRP Median International Reference Price, MDPR Median Drug Price Ratio
^aDrugs/Drug strengths without MIRP

ISSN: 1472-6963